Thoracic oncology
Symposium
State of the art session: Thoracic oncology
Translational
Aims : The 2018 lung cancer state of the art session will provide new perspectives on issues in lung cancer that remain unsolved. The session will start with a profound review of recent findings about tumour biology and then present a comprehensive update on multimodal strategies in three prognosis-determining treatment areas.
Target audience :
Clinical researcher, General practitioner, Nurse, Pathologist, Patient, Radiologist, Scientist (basic, translational), Student, Thoracic oncologist, Thoracic surgeon, Trainee, Adult pulmonologist/Clinician
Methods :
Cell and molecular biology, Endoscopy and interventional pulmonology, Epidemiology, General respiratory patient care, Imaging, Public health, Surgery, Transplantation
08:30
The latest in lung cancer tumour biology
C. Mascaux(Strasbourg, France)
COI
-
Description
1
1897
09:00
Lung cancer and interstitial lung disease
J. Cadranel(Paris Cedex 20, France)
COI
-
Description
2
1898
09:25
Multimodal management of brain metastases in lung cancer
T. Blum(Berlin, Germany)
COI
-
Description
3
1899
09:50
Rational approaches to pleural malignancies
J. van Meerbeeck(Edegem (Antwerp), Belgium)
COI
-
Description
4
1900
10:15
ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe
A. Rich(Nottingham (Nottinghamshire), United Kingdom)
COI
5
1901
. . .
